More than 10 years ago, we isolated from mouse embryonic dorsal aorta a population of vessel-associated stem/progenitor cells, originally named mesoangioblasts (MABs ), capable to differentiate in all mesodermal-derived tissues, including skeletal muscle. Similar though not identical cells have been later isolated and characterized from small vessels of adult mouse and human skeletal muscles. When delivered through the arterial circulation, MABs cross the blood vessel wall and participate in skeletal muscle regeneration, leading to an amelioration of muscular dystrophies in different preclinical animal models. As such, human MABs have been used under clinical-grade conditions for a Phase I/II clinical trial for Duchenne muscular dystrophy, just concluded. Although some pericyte markers can be used to identify mouse and human MABs, no single unequivocal marker can be used to isolate MABs. As a result, MABs are mainly defined by their isolation method and functional properties. This chapter provides detailed methods for isolation, culture, and characterization of MABs in light of the recent identification of a new marker, PW1/Peg3, to screen and identify competent MABs before their use in cell therapy.
Isolation and characterization of vessel-associated stem/progenitor cells from skeletal muscle / T. Rossana, G. Rossi, G. Messina (METHODS IN MOLECULAR BIOLOGY). - In: Muscle Stem Cells : Methods and Protocols / [a cura di] E. Perdiguero, D.D.W. Cornelison. - [s.l] : Humana Press, 2017. - ISBN 9781493967698. - pp. 149-177 [10.1007/978-1-4939-6771-1_8]
Isolation and characterization of vessel-associated stem/progenitor cells from skeletal muscle
G. Rossi;G. Messina
2017
Abstract
More than 10 years ago, we isolated from mouse embryonic dorsal aorta a population of vessel-associated stem/progenitor cells, originally named mesoangioblasts (MABs ), capable to differentiate in all mesodermal-derived tissues, including skeletal muscle. Similar though not identical cells have been later isolated and characterized from small vessels of adult mouse and human skeletal muscles. When delivered through the arterial circulation, MABs cross the blood vessel wall and participate in skeletal muscle regeneration, leading to an amelioration of muscular dystrophies in different preclinical animal models. As such, human MABs have been used under clinical-grade conditions for a Phase I/II clinical trial for Duchenne muscular dystrophy, just concluded. Although some pericyte markers can be used to identify mouse and human MABs, no single unequivocal marker can be used to isolate MABs. As a result, MABs are mainly defined by their isolation method and functional properties. This chapter provides detailed methods for isolation, culture, and characterization of MABs in light of the recent identification of a new marker, PW1/Peg3, to screen and identify competent MABs before their use in cell therapy.File | Dimensione | Formato | |
---|---|---|---|
Methods in Mol Biol Tonlorenzi et al., 2017.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.33 MB
Formato
Adobe PDF
|
1.33 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.